Zimmer Biomet Holdings PE Ratio 2006-2018 | ZBH

Current and historical p/e ratio for Zimmer Biomet Holdings (ZBH) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zimmer Biomet Holdings PE ratio as of January 18, 2019 is 13.93.
Zimmer Biomet Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-01-18 105.34 12.11
2018-09-30 131.47 $8.70 15.11
2018-06-30 111.44 $8.39 13.28
2018-03-31 108.81 $8.39 12.97
2017-12-31 120.14 $9.01 13.33
2017-09-30 116.35 $3.18 36.59
2017-06-30 127.32 $3.48 36.59
2017-03-31 120.86 $2.42 49.94
2016-12-31 101.94 $1.47 69.35
2016-09-30 128.13 $1.28 100.10
2016-06-30 118.41 $0.61 194.11
2016-03-31 104.67 $-0.14 0.00
2015-12-31 100.48 $0.36 279.11
2015-09-30 91.80 $1.13 81.24
2015-06-30 106.50 $1.98 53.79
2015-03-31 114.36 $3.92 29.17
2014-12-31 110.16 $4.19 26.29
2014-09-30 97.48 $4.64 21.01
2014-06-30 100.47 $4.58 21.94
2014-03-31 91.30 $4.44 20.56
2013-12-31 89.75 $4.43 20.26
2013-09-30 78.94 $3.95 19.98
2013-06-30 71.84 $4.07 17.65
2013-03-31 71.92 $4.40 16.34
2012-12-31 63.56 $4.29 14.82
2012-09-30 64.31 $4.28 15.02
2012-06-30 61.04 $4.27 14.30
2012-03-31 60.79 $4.11 14.79
2011-12-31 50.37 $4.02 12.53
2011-09-30 50.43 $3.33 15.14
2011-06-30 59.60 $3.28 18.17
2011-03-31 57.08 $3.04 18.78
2010-12-31 50.62 $2.97 17.04
2010-09-30 49.35 $3.53 13.98
2010-06-30 50.97 $3.27 15.59
2010-03-31 55.83 $3.43 16.28
2009-12-31 55.74 $3.33 16.74
2009-09-30 50.40 $3.34 15.09
2009-06-30 40.17 $3.59 11.19
2009-03-31 34.42 $3.60 9.56
2008-12-31 38.12 $3.71 10.27
2008-09-30 60.88 $4.08 14.92
2008-06-30 64.17 $3.32 19.33
2008-03-31 73.42 $3.30 22.25
2007-12-31 62.38 $3.26 19.13
2007-09-30 76.37 $3.16 24.17
2007-06-30 80.05 $3.73 21.46
2007-03-31 80.54 $3.57 22.56
2006-12-31 73.91 $3.41 21.68
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $21.487B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.437B 25.42
Medtronic (MDT) Ireland $117.248B 17.53
Stryker (SYK) United States $62.695B 23.63
Boston Scientific (BSX) United States $52.155B 26.36
Baxter (BAX) United States $37.585B 24.27
ResMed (RMD) United States $16.792B 32.02
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
Canopy Growth (CGC) Canada $10.104B 0.00
Bio-Rad Laboratories (BIO) United States $7.180B 45.91
Hill-Rom Holdings (HRC) United States $6.608B 20.68
Aurora Cannabis (ACB) Canada $6.428B 33.90
Perrigo (PRGO) Ireland $6.245B 9.48
Haemonetics (HAE) United States $5.216B 45.87
ICU Medical (ICUI) United States $4.878B 27.18
Insulet (PODD) United States $4.428B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.141B 0.00
Agios Pharmaceuticals (AGIO) United States $3.252B 0.00
Neogen (NEOG) United States $3.150B 48.38
Hutchison China MediTech (HCM) China $2.945B 0.00
National Vision Holdings (EYE) United States $2.566B 49.63
NuVasive (NUVA) United States $2.469B 22.98
Quidel (QDEL) United States $2.084B 27.17
NxStage Medical (NXTM) United States $1.901B 0.00
Aphria (APHA) $1.668B 74.22
Phibro Animal Health (PAHC) United States $1.294B 18.32
AtriCure (ATRC) United States $1.222B 0.00
VAREX IMAGING (VREX) United States $1.060B 21.23
Cardiovascular Systems (CSII) United States $1.013B 1457.00
PetIQ (PETQ) United States $0.781B 20.25
Cerus (CERS) United States $0.771B 0.00
OraSure Technologies (OSUR) United States $0.747B 42.03
Meridian Bioscience (VIVO) United States $0.713B 22.73
Eagle Pharmaceuticals (EGRX) United States $0.662B 21.24
Omeros (OMER) United States $0.658B 0.00
Surmodics (SRDX) United States $0.642B 97.18
Lantheus Holdings (LNTH) United States $0.637B 19.73
NanoString Technologies (NSTG) United States $0.624B 0.00
MacroGenics (MGNX) United States $0.520B 0.00
Quanterix (QTRX) United States $0.467B 0.00
LeMaitre Vascular (LMAT) United States $0.458B 22.48
Owens & Minor (OMI) United States $0.453B 5.12
Evolus (EOLS) United States $0.436B 0.00
TG Therapeutics (TGTX) United States $0.375B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.85
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.279B 0.00
Bovie Medical (APYX) United States $0.278B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.244B 0.00
BioLife Solutions (BLFS) United States $0.226B 305.00
Rockwell Medical (RMTI) United States $0.198B 0.00
Fonar (FONR) United States $0.139B 7.00
Chimerix (CMRX) United States $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
United-Guardian (UG) United States $0.090B 18.85
Female Health (VERU) United States $0.084B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 18.07
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00